425: Strive CRO Reposts Merger Update with Semler Scientific

Strive's Chief Risk Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, including cautionary forward-looking statements.

Summary

• Strive, Inc. (Strive) and Semler Scientific, Inc. (Semler Scientific) are engaged in a proposed business combination.
• The communication, reposted by Jeff Walton, Strive's Chief Risk Officer, on December 31, 2025, serves as a cautionary statement regarding forward-looking statements related to the merger.
• Forward-looking statements include expectations for the transaction, strategic and financial benefits, impact on future financial performance, closing timing, and integration success.
• The filing emphasizes that actual results could differ materially from anticipated results due to various risks and uncertainties.
• Investors and stockholders are urged to read the Registration Statement on Form S-4, including the Information Statement/Proxy Statement/Prospectus, and other relevant SEC filings for comprehensive information.

Sentiment

Score: 5

Explanation: The filing is a procedural communication regarding a proposed merger, primarily serving as a cautionary statement about forward-looking information and directing readers to other SEC documents. It does not contain new financial results or operational updates that would significantly sway sentiment positively or negatively, beyond the inherent risks associated with any merger.

Positives

• Anticipated strategic benefits and financial benefits of the proposed transaction, including the expected positive impact on the combined company's future financial performance, are forward-looking statements.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, the implementation of Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The future outlook for Strive and Semler Scientific is centered on the successful completion and integration of their proposed business combination. Forward-looking statements anticipate strategic and financial benefits, including a positive impact on the combined company's future financial performance. However, these statements are subject to significant risks and uncertainties, including those related to general economic conditions, market factors, regulatory changes, and the integration process itself, which could cause actual results to differ materially.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication on X.com regarding the proposed business combination.

Industry Context

This announcement relates to a specific merger within the financial or healthcare technology sectors (depending on Semler's primary business, which is not detailed here beyond the merger context). The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests Strive, or the combined entity, may be engaging with or exposed to the digital asset industry, reflecting a broader trend of corporate adoption or consideration of digital assets.

Corporate Governance

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Stakeholder Impact

• Shareholders of Semler Scientific will be impacted by the proposed transaction, requiring their approval and potentially receiving Strive Class A common stock.
• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock for the merger.
• Customers of both Strive and Semler Scientific could have adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Employees of both companies may experience changes to their relationships or roles due to the merger and integration process.

Next Steps

• Stockholders of Semler Scientific are required to approve the proposed transaction.
• Strive will issue Class A common stock in connection with the proposed transaction.
• The combined businesses will undergo integration post-merger.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Forward-Looking Statements, Corporate Governance, Risk Management, Bitcoin Treasury Strategies, Digital Assets